Moonshot
Open Letter from Biopharmaceutical R&D Leaders to the Biden Administration: Your Policies Are Undermining the Cancer Moonshot
America’s biopharmaceutical companies share President Biden’s commitment to eradicating cancer. With more than 1,300 medicines in the research pipeline, the science has never been more promising. But as industry research and development leaders warn in a letter to the Biden Administration, the Cancer Moonshot might have to call off its mission before it can get off the ground.
Related Resources
Blog Post
R&D leaders to Biden Administration Your policies are undermining the Cancer Moonshot
As industry research and development leaders warn in a new letter to the Biden Administration, the Cancer Moonshot might have to call off its mission before it can get off the ground.
Cancer Moonshot Print Ad
Cancer Moonshot Print Ad
Inflation Reduction Act Could Have Devastating Consequences for Americans
The Inflation Reduction Act puts patients’ access to medicines on the line.